"Dr. Sussman is an Allergist and Clinical Immunologist practicing in the North York area. Our clinic has been treating patients in Toronto and the surrounding area for over 30 years. Dr. Sussman’s expertise in investigator initiated clinical trials and his insight into patient care have lead to numerous developments in allergy treatments and discoveries."

During the past decade, Gordon Sussman Clinical Research, Inc. conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 13 clinical trials were completed, i.e. on average, 61.9% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 12 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gordon Sussman Clinical Research, Inc." #1 sponsor was "DBV Technologies" with 7 trials, followed by "Aimmune Therapeutics, Inc." with 5 trials sponsored, "Amgen" with 2 trials sponsored, "CSL Behring" with 2 trials sponsored and "Green Cross Corporation" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gordon Sussman Clinical Research, Inc." #1 collaborator was "Atlantic Research Group" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Dyax Corp." with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Gordon Sussman Clinical Research, Inc." are "Peanut Allergy" (10 trials), "Atopic Dermatitis" (2 trials), "Hereditary Angioedema" (2 trials), "Hereditary Angioedema (HAE)" (2 trials) and "Agammaglobulinemia" (1 trials). Many other conditions were trialed in "Gordon Sussman Clinical Research, Inc." in a lesser frequency.

Most popular intervention types in "Gordon Sussman Clinical Research, Inc." are "Biological" (16 trials), "Drug" (10 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "AR101" (4 trials), "Viaskin Peanut 250 mcg" (3 trials), "CSL312" (2 trials) and "Viaskin Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gordon Sussman Clinical Research, Inc." are 25 trials for "All" genders.

Currently, there are NaN active trials in "Gordon Sussman Clinical Research, Inc.". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 17 completed trials in Gordon Sussman Clinical Research, Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Gordon Sussman Clinical Research, Inc., 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".